Surgical Innovations Group plc (AIM:SUN)
London · Delayed Price · Currency is GBP · Price in GBX 0.3661
-0.0339 (-8.48%)
Oct 2, 2026, 2:44 PM GMT
AIM:SUN Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11.48 | 11.6 | 11.95 | 12.01 | 11.34 | 9.13 | |
Revenue Growth | -3.68% | -2.87% | -0.57% | 5.94% | 24.26% | 44.19% |
Cost of Revenue | 8.6 | 8.55 | 8.51 | 8.57 | 7.42 | 6 |
Gross Profit | 2.88 | 3.05 | 3.44 | 3.45 | 3.92 | 3.13 |
Selling, General & Admin | - | - | 2.71 | 2.63 | 2.42 | 2.13 |
Research & Development | - | - | 1.15 | 1.1 | 1.16 | 0.97 |
Amortization of Goodwill & Intangibles | - | - | 0.21 | 0.28 | 0.23 | 0.4 |
Other Operating Expenses | 3.9 | 3.78 | - | - | - | - |
Operating Expenses | 3.9 | 3.78 | 4.07 | 4.04 | 3.85 | 3.53 |
Operating Income | -1.02 | -0.73 | -0.64 | -0.59 | 0.07 | -0.4 |
Interest Expense | -0.04 | -0.07 | -0.1 | -0.13 | -0.1 | -0.13 |
EBT Excluding Unusual Items | -1.06 | -0.79 | -0.74 | -0.72 | -0.03 | -0.53 |
Asset Writedown | -0.15 | -0.15 | -1.16 | - | - | - |
Other Unusual Items | - | - | -0.15 | -0.01 | -0.03 | -0.05 |
Pretax Income | -1.21 | -0.94 | -2.05 | -0.73 | -0.06 | -0.59 |
Income Tax Expense | -0.05 | -0.05 | -0.11 | -0.22 | -0.32 | -0.13 |
Net Income | -1.16 | -0.9 | -1.94 | -0.51 | 0.26 | -0.46 |
Net Income to Common | -1.16 | -0.9 | -1.94 | -0.51 | 0.26 | -0.46 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 821 | 933 | 933 | 933 | 933 | 937 |
Shares Outstanding (Diluted) | 821 | 933 | 933 | 933 | 936 | 939 |
Shares Change | -17.17% | - | - | -0.33% | -0.30% | 12.18% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.97 | 0.51 | -0.14 | 0.12 | -0.17 | -0.65 |
Free Cash Flow Per Share | 0.00 | 0.00 | - | - | - | -0.00 |
Gross Margin | 25.10% | 26.31% | 28.77% | 28.70% | 34.59% | 34.31% |
Operating Margin | -8.88% | -6.28% | -5.34% | -4.89% | 0.64% | -4.41% |
Profit Margin | -10.14% | -7.71% | -16.27% | -4.24% | 2.33% | -5.00% |
Free Cash Flow Margin | 8.43% | 4.38% | -1.18% | 0.97% | -1.53% | -7.07% |
EBITDA | -0.8 | -0.5 | -0.37 | -0.34 | 0.24 | -0.14 |
EBITDA Margin | -6.94% | -4.33% | -3.12% | -2.85% | 2.12% | -1.58% |
D&A For EBITDA | 0.22 | 0.23 | 0.27 | 0.25 | 0.17 | 0.26 |
EBIT | -1.02 | -0.73 | -0.64 | -0.59 | 0.07 | -0.4 |
EBIT Margin | -8.88% | -6.28% | -5.34% | -4.89% | 0.64% | -4.41% |